Puncture site closure market growing fast as new treatment procedures cut time and money
This article was originally published in Clinica
The worldwide market for arterial puncture site closure devices is growing by 10%-15% annually and represents a market opportunity of nearly $1 billion. However, only a handful of companies are involved, with Perclose, which already has 25% of the market, providing the best solution, according to an industry report by analysts BT Alex Brown.
You may also be interested in...
Novartis has long championed the idea of making Sandoz an autonomous unit within the Swiss originator while stopping short of carving out the business altogether. Rumors continue to swirl around a potential deal, which was discussed during the recent virtual Meet Novartis Management event.
Health technology assessment body says that while iRhythm Technologies’ Zio XT service improves cardiac arrhythmia detection, more data must be collected to address evidence gaps about its benefit.
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.